Bank Of America Corp Instil Bio, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.51 - $0.67 $48,074 - $63,156	-94,263 Reduced 96.54%	3,374 $1,000
Q1 2023 May 12, 2023	BUY	$0.6 - $0.91 $28,221 - $42,802	47,036 Added 92.95%	97,637 $64,000
Q4 2022 Feb 10, 2023	BUY	$0.48 - $5.33 $16,122 - $179,024	33,588 Added 197.43%	50,601 $31,000
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $8,644 - $13,700	-1,859 Reduced 9.85%	17,013 $82,000
Q2 2022 Aug 12, 2022	SELL	$4.21 - $11.15 $45,762 - $121,200	-10,870 Reduced 36.55%	18,872 $87,000
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $60,962 - $130,120	7,189 Added 31.88%	29,742 $320,000
Q4 2021 Feb 08, 2022	BUY	$15.37 - $22.5 $312,656 - $457,695	20,342 Added 920.04%	22,553 $386,000
Q3 2021 Nov 15, 2021	SELL	$15.05 - $23.28 $7,946 - $12,291	-528 Reduced 19.28%	2,211 $40,000
Q2 2021 Sep 13, 2021	BUY	$15.31 - $24.63 $41,934 - $67,461	2,739 New	2,739 $53,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.